Tag:
Mundipharma International
Latest Headlines
Latest Headlines
Mundipharma tacks on $50M to cancer alliance with Infinity
Infinity Pharmaceuticals ( $INFI ) has some new wiggle room in its budget to develop its PI3K inhibitor intended to combat blood cancers and inflammation. Mundipharma International, Infinity's partner
Allos inks $360M Folotyn pact as cancer drug sales disappoint
After disappointing analysts with its sales numbers for Folotyn, Allos Therapeutics ( $ALTH ) turned around and announced an ex-North American licensing pact for the drug which will deliver $50 million
